NASDAQ:BSVNBank7 Stock Price, Forecast & News

Bank7's stock was trading at $9.97 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BSVN shares have increased by 4.0% and is now trading at $10.37. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bank7 in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bank7.

Bank7 is scheduled to release its next quarterly earnings announcement on Friday, July 24th 2020. View our earnings forecast for Bank7.

Bank7 Corp (NASDAQ:BSVN) posted its quarterly earnings results on Thursday, April, 30th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.14. The firm earned $11.76 million during the quarter, compared to the consensus estimate of $10.45 million. Bank7 had a net margin of 15.06% and a return on equity of 8.29%. View Bank7's earnings history.

Bank7 announced a quarterly dividend on Wednesday, March 18th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.10 per share on Tuesday, April 14th. This represents a $0.40 dividend on an annualized basis and a yield of 3.86%. The ex-dividend date is Monday, March 30th. View Bank7's dividend history.

3 brokers have issued twelve-month price targets for Bank7's shares. Their forecasts range from $12.00 to $14.00. On average, they anticipate Bank7's stock price to reach $13.00 in the next year. This suggests a possible upside of 25.4% from the stock's current price. View analysts' price targets for Bank7.

News coverage about BSVN stock has trended somewhat negative on Thursday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Bank7 earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View the latest news aboutBank7.

Bank7 saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 41,400 shares, an increase of 7.8% from the April 30th total of 38,400 shares. Based on an average daily trading volume, of 28,900 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.6% of the shares of the company are short sold. View Bank7's Current Options Chain.

Some companies that are related to Bank7 include Customers Bancorp (CUBI), Capital City Bank Group (CCBG), Midland States Bancorp (MSBI), Farmers National Banc (FMNB), Flushing Financial (FFIC), MidWestOne Financial Group (MOFG), Independent Bank Co.(MI) (IBCP), Business First Bancshares (BFST), West Bancorporation (WTBA), Red River Bancshares (RRBI), Cambridge Bancorp (CATC), Bridgewater Bancshares (BWB), MetroCity Bankshares (MCBS), Sierra Bancorp (BSRR) and Silvergate Capital (SI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bank7 investors own include Dominion Energy (D), Energy Transfer LP Unit (ET), AbbVie (ABBV), Algonquin Power & Utilities (AQN), Enterprise Products Partners (EPD), Intel (INTC), Altria Group (MO), Oragenics (OGEN), Pfizer (PFE) and Philip Morris International (PM).

(BSVN) raised $64 million in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 3,300,000 shares at $18.00-$21.00 per share. Keefe, Bruyette & Woods (A Stifel Company) and Stephens served as the underwriters for the IPO and Sandler O’Neill + Partners was co-manager.

Bank7 trades on the NASDAQ under the ticker symbol "BSVN."

Bank7's stock is owned by many different institutional and retail investors. Top institutional investors include Mendon Capital Advisors Corp (3.09%), BlackRock Inc. (2.28%), Alliancebernstein L.P. (1.94%), State Street Corp (0.73%), ELCO Management Co. LLC (0.57%) and Bank of New York Mellon Corp (0.38%). Company insiders that own Bank7 stock include Douglas A Haines, Gary D Whitcomb, J Michael Sanner, John T Phillips, Julee S Thummel, Kelly J Harris, Lisa K Haines, Thomas L Travis, William B Haines and William M Buergler. View institutional ownership trends for Bank7.

BSVN stock was sold by a variety of institutional investors in the last quarter, including Mendon Capital Advisors Corp, Alliancebernstein L.P., ELCO Management Co. LLC, New York State Common Retirement Fund, and Bank of New York Mellon Corp. View insider buying and selling activity for Bank7.

BSVN stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, and JPMorgan Chase & Co.. Company insiders that have bought Bank7 stock in the last two years include Douglas A Haines, Gary D Whitcomb, J Michael Sanner, John T Phillips, Kelly J Harris, Lisa K Haines, Thomas L Travis, and William M Buergler. View insider buying and selling activity for Bank7.

Shares of BSVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BSVN stock can currently be purchased for approximately $10.37.

Bank7 has a market capitalization of $95.67 million and generates $52.99 million in revenue each year. The company earns $8.23 million in net income (profit) each year or $1.96 on an earnings per share basis. Bank7 employs 72 workers across the globe.

The official website for Bank7 is www.bank7.com.

Bank7's mailing address is 1039 NW 63RD STREET, OKLAHOMA CITY OK, 73116. The company can be reached via phone at 405-810-8600.